English  |  正體中文  |  简体中文  |  Total items :2853524  
Visitors :  45207717    Online Users :  831
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"余明隆"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 131-140 of 247  (25 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

Institution Date Title Author
高雄醫學大學 2007 The Seroprevalence Of HBV And HCV Infection In Southern Taiwan- Large Scale Community-Based Study  莊萬龍;余明隆;戴嘉言;林嘉益;侯乃仁;李立柏;謝明彥;黃志富;謝明裕;張文宇 
高雄醫學大學 2007 Transforming Growth Factor-Beta 1 Gene Polymorphisms In High Dose IFN/Ribavirin treated CHC Patients  戴嘉言;余明隆;張文宇;李立柏;潘文正;侯乃仁;謝明彥;黃志富;陳信成;林子堯;謝明裕;王良彥;莊萬龍 
高雄醫學大學 2007 Early Mortality And Responses In Non-Cirrhotic Decompensated CHB Patients With Lamivudine Therapy  戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;陳信成;王良彥;張文宇;莊萬龍 
高雄醫學大學 2007 EARLY MORTALITY AND RESPONSES IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS  戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 
高雄醫學大學 2007 The presence of Antinuclear Antibody is associated with a negative response to combination therapy with peginterferon and ribavirin for patients without genotype 1 chronic hepatitis C infection  謝明彥;戴嘉言;黃志富;莊萬龍;侯乃仁;李立柏;陳信成;謝明裕;王良彥;張文宇;余明隆 
高雄醫學大學 2007 Pretreatment insulin sensitivity contributes to the treatment response to peginterferon plus ribavirin combination therapy for patients with chronic hepatitis C  黃志富;余明隆;戴嘉言;張文宇;莊萬龍 
高雄醫學大學 2007 CLINICAL EVALUATION OF THE ABBOTT REAL-TIME PCR ASSAY FOR QUANTIFICATION OF HEPATITIS C VIRUS INFECTION AMONG GENOTYPE-1 AND -2 PATIENTS IN TAIWAN- COMPARISON TO THE VERSANT HCV RNA 3.0 ASSAY  戴嘉言;黃志富;余明隆;莊萬龍;張文宇 
高雄醫學大學 2007 High chance of cure in HCV genotype 1 patients with a low viral load achieving an RVR treated for 24 wks with pegylated interferon alfa-2a (PEGASYS) plus ribavirin (COPEGUS): Prospective, randomized, controlled study comparing 24 & 48 wks of treatm  余明隆;戴嘉言;黃志富;李立柏;謝明彥;丘長富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍* 
高雄醫學大學 2007 PHARMACOGENOMICS STUDY FOR 24 VS. 48 WEEKS TREATMENT OF PEGINTERFERON PLUS RIBAVIRIN FOR GENOTYPE 1b CHRONIC HEPATITIS C  戴嘉言;黃志富;謝明彥;陳信成;余明隆;莊萬龍 
高雄醫學大學 2007 RELATIONSHIP BETWEEN GLUCOSE ABNORMALITIES AND RESPONSE TO PEGYLATED INTERFERON ALFA PLUS RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C PATIENTS  謝明彥;戴嘉言;黃志富;林子堯;余明隆;莊萬龍 

Showing items 131-140 of 247  (25 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page